The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

CHEMBL482477     (Z)-7-[(1S,5E)-5-[(E)-oct-2- enylidene]-4...

Synonyms: BSPBio_001361, HMDB05079, CHEBI:607727, AC1NSK7W, BML2-B05, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of AIDS039990


High impact information on AIDS039990


Chemical compound and disease context of AIDS039990


Biological context of AIDS039990


Anatomical context of AIDS039990


Associations of AIDS039990 with other chemical compounds


Gene context of AIDS039990


Analytical, diagnostic and therapeutic context of AIDS039990


  1. Tumor prevention and antitumor immunity with heat shock protein 70 induced by 15-deoxy-delta12,14-prostaglandin J2 in transgenic adenocarcinoma of mouse prostate cells. Vanaja, D.K., Grossmann, M.E., Celis, E., Young, C.Y. Cancer Res. (2000) [Pubmed]
  2. Prostaglandin J2 and 15-deoxy-delta12,14-prostaglandin J2 induce proliferation of cyclooxygenase-depleted colorectal cancer cells. Chinery, R., Coffey, R.J., Graves-Deal, R., Kirkland, S.C., Sanchez, S.C., Zackert, W.E., Oates, J.A., Morrow, J.D. Cancer Res. (1999) [Pubmed]
  3. Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-Delta12, 14-prostaglandin J2. Bishop-Bailey, D., Hla, T. J. Biol. Chem. (1999) [Pubmed]
  4. Peroxisome proliferator-activated receptor gamma and growth inhibition by its ligands in uterine endometrial carcinoma. Ota, K., Ito, K., Suzuki, T., Saito, S., Tamura, M., Hayashi, S., Okamura, K., Sasano, H., Yaegashi, N. Clin. Cancer Res. (2006) [Pubmed]
  5. 15-Deoxy-delta12,14-prostaglandin J2-induced apoptosis does not require PPARgamma in breast cancer cells. Clay, C.E., Monjazeb, A., Thorburn, J., Chilton, F.H., High, K.P. J. Lipid Res. (2002) [Pubmed]
  6. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Forman, B.M., Tontonoz, P., Chen, J., Brun, R.P., Spiegelman, B.M., Evans, R.M. Cell (1995) [Pubmed]
  7. Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma. Bell-Parikh, L.C., Ide, T., Lawson, J.A., McNamara, P., Reilly, M., FitzGerald, G.A. J. Clin. Invest. (2003) [Pubmed]
  8. Physiological levels of 15-deoxy-Delta12,14-prostaglandin J2 prime eotaxin-induced chemotaxis on human eosinophils through peroxisome proliferator-activated receptor-gamma ligation. Kobayashi, Y., Ueki, S., Mahemuti, G., Chiba, T., Oyamada, H., Saito, N., Kanda, A., Kayaba, H., Chihara, J. J. Immunol. (2005) [Pubmed]
  9. Expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma and levels of prostaglandin E2 and 15-deoxy-delta12,14-prostaglandin J2 in human breast cancer and metastasis. Badawi, A.F., Badr, M.Z. Int. J. Cancer (2003) [Pubmed]
  10. Cyclopentenone prostaglandins PGA2 and 15-deoxy-delta12,14 PGJ2 suppress activation of murine microglia and astrocytes: implications for multiple sclerosis. Storer, P.D., Xu, J., Chavis, J.A., Drew, P.D. J. Neurosci. Res. (2005) [Pubmed]
  11. Ligands of peroxisome proliferator-activated receptor gamma induce apoptosis in multiple myeloma. Eucker, J., Bängeroth, K., Zavrski, I., Krebbel, H., Zang, C., Heider, U., Jakob, C., Elstner, E., Possinger, K., Sezer, O. Anticancer Drugs (2004) [Pubmed]
  12. Effects of 15-deoxy-Delta12,14-prostaglandin J2 on the expression of Toll-like receptor 4 and 2 in the murine lung in the presence of lipopolysaccharide. Inoue, K., Takano, H., Yanagisawa, R., Ichinose, T., Sadakane, K., Yoshino, S., Yamaki, K., Uchiyama, K., Yoshikawa, T. Clin. Exp. Pharmacol. Physiol. (2005) [Pubmed]
  13. Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells. Hashimoto, K., Ethridge, R.T., Evers, B.M. International journal of gastrointestinal cancer. (2002) [Pubmed]
  14. 15-deoxy-delta12,14-prostaglandin J2 inhibits Bay 11-7085-induced sustained extracellular signal-regulated kinase phosphorylation and apoptosis in human articular chondrocytes and synovial fibroblasts. Relic, B., Benoit, V., Franchimont, N., Ribbens, C., Kaiser, M.J., Gillet, P., Merville, M.P., Bours, V., Malaise, M.G. J. Biol. Chem. (2004) [Pubmed]
  15. 15-deoxy-delta12,14-prostaglandin J2-mediated ERK signaling inhibits gram-negative bacteria-induced RelA phosphorylation and interleukin-6 gene expression in intestinal epithelial cells through modulation of protein phosphatase 2A activity. Ruiz, P.A., Kim, S.C., Sartor, R.B., Haller, D. J. Biol. Chem. (2004) [Pubmed]
  16. Identification of ARA70 as a ligand-enhanced coactivator for the peroxisome proliferator-activated receptor gamma. Heinlein, C.A., Ting, H.J., Yeh, S., Chang, C. J. Biol. Chem. (1999) [Pubmed]
  17. Tumor necrosis factor alpha-induced pancreatic beta-cell insulin resistance is mediated by nitric oxide and prevented by 15-deoxy-Delta12,14-prostaglandin J2 and aminoguanidine. A role for peroxisome proliferator-activated receptor gamma activation and inos expression. Kwon, G., Xu, G., Marshall, C.A., McDaniel, M.L. J. Biol. Chem. (1999) [Pubmed]
  18. Novel binding sites of 15-deoxy-Delta12,14-prostaglandin J2 in plasma membranes from primary rat cortical neurons. Yagami, T., Ueda, K., Asakura, K., Takasu, N., Sakaeda, T., Itoh, N., Sakaguchi, G., Kishino, J., Nakazato, H., Katsuyama, Y., Nagasaki, T., Okamura, N., Hori, Y., Hanasaki, K., Arimura, A., Fujimoto, M. Exp. Cell Res. (2003) [Pubmed]
  19. The 15-deoxy-delta12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma. Giri, S., Rattan, R., Singh, A.K., Singh, I. J. Immunol. (2004) [Pubmed]
  20. 15-deoxy-Delta12,14-prostaglandin J2 inhibits IFN-inducible protein 10/CXC chemokine ligand 10 expression in human microglia: mechanisms and implications. Si, Q., Zhao, M.L., Morgan, A.C., Brosnan, C.F., Lee, S.C. J. Immunol. (2004) [Pubmed]
  21. 15-deoxy-Delta12,14-prostaglandin J2 inhibits glucocorticoid binding and signaling in macrophages through a peroxisome proliferator-activated receptor gamma-independent process. Cheron, A., Peltier, J., Perez, J., Bellocq, A., Fouqueray, B., Baud, L. J. Immunol. (2004) [Pubmed]
  22. Activation of peroxisome proliferator-activated receptor-gamma inhibits the Runx2-mediated transcription of osteocalcin in osteoblasts. Jeon, M.J., Kim, J.A., Kwon, S.H., Kim, S.W., Park, K.S., Park, S.W., Kim, S.Y., Shin, C.S. J. Biol. Chem. (2003) [Pubmed]
  23. Ligands of peroxisome proliferator-activated receptor-gamma block activation of pancreatic stellate cells. Masamune, A., Kikuta, K., Satoh, M., Sakai, Y., Satoh, A., Shimosegawa, T. J. Biol. Chem. (2002) [Pubmed]
  24. 15d-PGJ2 and rosiglitazone suppress Janus kinase-STAT inflammatory signaling through induction of suppressor of cytokine signaling 1 (SOCS1) and SOCS3 in glia. Park, E.J., Park, S.Y., Joe, E.H., Jou, I. J. Biol. Chem. (2003) [Pubmed]
  25. Anti-inflammatory activity of 15-deoxy-delta12,14-PGJ2 and 2-cyclopenten-1-one: role of the heat shock response. Ianaro, A., Ialenti, A., Maffia, P., Di Meglio, P., Di Rosa, M., Santoro, M.G. Mol. Pharmacol. (2003) [Pubmed]
  26. Inhibition of nuclear translocation of nuclear factor-kappaB despite lack of functional IkappaBalpha protein overcomes multiple defects in apoptosis signaling in human B-cell malignancies. Thomas, R.K., Sos, M.L., Zander, T., Mani, O., Popov, A., Berenbrinker, D., Smola-Hess, S., Schultze, J.L., Wolf, J. Clin. Cancer Res. (2005) [Pubmed]
  27. 15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) and ciglitazone modulate Staphylococcus aureus-dependent astrocyte activation primarily through a PPAR-gamma-independent pathway. Phulwani, N.K., Feinstein, D.L., Gavrilyuk, V., Akar, C., Kielian, T. J. Neurochem. (2006) [Pubmed]
  28. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism. Farrajota, K., Cheng, S., Martel-Pelletier, J., Afif, H., Pelletier, J.P., Li, X., Ranger, P., Fahmi, H. Arthritis Rheum. (2005) [Pubmed]
  29. 15-Deoxy-delta12,14-prostaglandin J2 regulates leukemia inhibitory factor signaling through JAK-STAT pathway in mouse embryonic stem cells. Rajasingh, J., Bright, J.J. Exp. Cell Res. (2006) [Pubmed]
  30. Differential peroxisome proliferator-activated receptor-gamma isoform expression and agonist effects in normal and malignant prostate cells. Subbarayan, V., Sabichi, A.L., Kim, J., Llansa, N., Logothetis, C.J., Lippman, S.M., Menter, D.G. Cancer Epidemiol. Biomarkers Prev. (2004) [Pubmed]
  31. Potentiation of tumor formation by topical administration of 15-deoxy-delta12,14-prostaglandin J2 in a model of skin carcinogenesis. Millán, O., Rico, D., Peinado, H., Zarich, N., Stamatakis, K., Pérez-Sala, D., Rojas, J.M., Cano, A., Boscá, L. Carcinogenesis (2006) [Pubmed]
  32. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut. Cuzzocrea, S., Pisano, B., Dugo, L., Ianaro, A., Patel, N.S., Di Paola, R., Genovese, T., Chatterjee, P.K., Di Rosa, M., Caputi, A.P., Thiemermann, C. Br. J. Pharmacol. (2003) [Pubmed]
  33. 15-Deoxy-Delta12,14-prostaglandin J2 enhances docetaxel anti-tumor activity against A549 and H460 non-small-cell lung cancer cell lines and xenograft tumors. Fulzele, S.V., Chatterjee, A., Shaik, M.S., Jackson, T., Ichite, N., Singh, M. Anticancer Drugs (2007) [Pubmed]
  34. Identification and regulation of novel PPAR-gamma splice variants in human THP-1 macrophages. Chen, Y., Jimenez, A.R., Medh, J.D. Biochim. Biophys. Acta (2006) [Pubmed]
WikiGenes - Universities